Table 1.
Phosgene | Chlorine | |
---|---|---|
Subjective symptoms | Absent | Eye and airway irritation |
Sensory irritation-URT | Absent | Marked |
Bronchial airway injury | Minimal, if any | Marked |
Surfactant deterioration | Marked | Dose-dependent |
Sensory irritation-LRT | Marked | Dose-dependent |
Alveolar macrophage injury | Marked | Dose-dependent |
Pulmonary vascular dysfunction | Marked | Dose-dependent |
Cardiopulmonary dysfunction | Marked | Marked |
Early lung edema | Extreme doses | Dose-dependent |
Onset of lung edema | Maximum 15–20 h | Instant |
Primary countermeasure | Lung edema | Lung edema & obliterating airway injury |
Secondary countermeasure | Rapid recovery | Lingering airway injury |
Clinical guidance on inhaled dose | Phosgene dosimeters | Environmental analyses (if available) |
Prognostic approaches | Hemoglobin, eNO, eCO2 | Irritation severity, fibrin |
URT upper respiratory tract, LRT lower respiratory tract, eNO exhaled nitric oxide, eCO 2 exhaled carbon dioxide